← Leaderboards
Alice Scott Mims
Ohio State University
$1,588,136
Attributed
$4,935,277
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,935,277 · 3
By mechanism
R01$4,935,277 · 3
Top collaborators
- Rosa Lapalombella5 shared
- Deepa Sampath5 shared
- Ann-Kathrin Eisfeld3 shared
- Elaine R Mardis3 shared
- John C Byrd1 shared
- Christopher C. Coss1 shared
- Erin K Hertlein1 shared
Most similar at Ohio State University
Same institution · by research overlap
- Rosa Lapalombella$5,349,017
- Deepa Sampath$2,215,864
- Jennifer A. Woyach$6,733,332
- Shujun Liu$5,854,035
- Amy Jo Johnson$2,112,180
Others in their field
Other Emerging Leaders on “Enzymes”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Jacob Ruff · Cornell University$22,500,000
- Elke Arenholz · Cornell University$14,750,000
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$14,335,772
- Amitinder Kaur · Tulane University Of Louisiana$12,771,713
Research focus
EnzymesIn VivoResponseTargeted TreatmentMediatingRelapseCellsMutationDisease ProgressionLeukemiaMouse ModelEpigenetic ProcessDiagnosisHematopoieticCytotoxicImpairmentCombined Modality TherapyOutcome StudyTargeted AgentBiologicalBaseMitochondriaMolecular SubtypesApoptosis
Grant awards (9)
Pharmacodynamically directed targeted therapy for leukemia$683,472
R01 · FY2025 · CA
Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML$617,933
R01 · FY2024 · CA
Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML$637,871
R01 · FY2023 · CA
Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML$664,967
R01 · FY2022 · CA
Targeting NAMPT in Acute Myeloid Leukemia$461,498
R01 · FY2022 · CA
Targeting NAMPT in Acute Myeloid Leukemia$470,916
R01 · FY2021 · CA
Targeting NAMPT in Acute Myeloid Leukemia$470,916
R01 · FY2020 · CA
Targeting NAMPT in Acute Myeloid Leukemia$456,788
R01 · FY2019 · CA
Targeting NAMPT in Acute Myeloid Leukemia$470,916
R01 · FY2018 · CA